Surgical Biologics will operate as a wholly owned subsidiary of MiMedx Group. The company’s product portfolio includes the Purion process that follows strict guidelines for allograft processing.
MiMedx projects that 2011 company revenues from the acquisition will be in the range of $7 million.
Read the MiMedx news release on the acquisition.
Read other coverage on orthopedic and spine device acquisitions:
– DJO Acquires Elastic Therapy
– Zimmer Finalizes Acquisition of Beijing Montagne Medical Device Co.
– Hanger Orthopedic Group Completes Acquisition of Accelerated Care Plus
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
